Crista Eggers, left, the campaign coordinator for Nebraskans for Medical Marijuana, accepts petitions from a volunteer, Samantha Chavez of Omaha, in June 2022. If the group is successful in its bid, Nebraska will join Florida and South Dakota in asking voters this fall whether to legalize some marijuana use. Paul Hammel/Nebraska Examiner
Nebraskan Crista Eggers is running up against a July 3 deadline. If she can get at least 87,000 names onto each of two petitions before then, she can put an initiative on the state’s November ballot that would legalize pot for medicinal purposes.
The petition effort is personal. Her 9-year-old son, Colton, has epilepsy and severe seizures, and medicinal cannabis can be prescribed to treat such conditions.
“I’m a caregiver to a child that needs medical cannabis access. Ninety-five percent of our people collecting [signatures] are Nebraskans who know someone who needs access and needs this issue on the ballot,” said Eggers, an Omaha resident and the campaign manager for Nebraskans for Medical Marijuana.
If the group is successful, Nebraska will join Florida and South Dakota in asking voters this fall whether to legalize some marijuana use. In Florida and South Dakota, where medical marijuana is already allowed, voters will be asked to legalize adult recreational use.
Thirty-eight states and the District of Columbia allow the medical use of cannabis products, and 24 plus the District of Columbia allow adults to use it recreationally, according to the National Conference of State Legislatures. Cannabis is still illegal under federal law, but 74% of Americans now live in a state where marijuana is legal for either recreational or medical use according to the Pew Research Center, and 54% live in a place where it is legal for recreational use.
Many states, especially left-leaning ones, have legalized marijuana through legislation, but “there are some states where the state legislators still don’t want to touch this issue of cannabis legislation, particularly in more conservative parts of the country,” said Beau Kilmer, co-director of the RAND Drug Policy Research Center.
“That’s why it’s not a surprise when cannabis issues go through the ballot initiative process,” Kilmer said.
H/T: www.yahoo.com
